Action HIK HIKMA PHARMACEUTICALS PLC
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Hikma Pharmaceuticals PLC

Actions

HIK

GB00B0LCW083

Temps réel estimé Cboe Europe
Autres places de cotation
 10:48:34 16/07/2024 		Varia. 5j. Varia. 1 janv.
1 827 GBX -0,54 % Graphique intraday de Hikma Pharmaceuticals PLC +0,99 % +2,18 %
24/06 Teva lance la version générique du médicament contre le diabète Victoza de Novo Nordisk RE
20/06 Fitch confirme les notations et les perspectives de Hikma Pharmaceuticals en raison de sa "position défensive sur le marché". MT

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Xellia Pharmaceuticals to focus on the manufacturing and commercialization of its life-saving anti-infectives portfolio through its global B2B partners
AQ
Hikma acquires Xellia s differentiated portfolio and enhances Injectables pipeline, manufacturing capabilities and R&D
AQ
Hikma Pharmaceuticals : Special Business passed at AGM
PU
Hikma appoints Dr. Hafrun Fridriksdottir as President of Generics business
AQ
Hikma launches Fentanyl Citrate Injection, USP, in a prefilled syringe in the US
AQ
Hikma Pharmaceuticals PLC - Notice of preliminary results
AQ
Activ Surgical, a Hikma Ventures portfolio company, completes the first international procedure using ActivSight Intelligent Light at Abdali Hospital in Jordan
AQ
Activ Surgical Announces Completion of First International Procedure Using Its ActivSight Intelligent Light
AQ
Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa
BU
Hikma launches Phenylephrine HCl Injection, USP, in ready-to-use vials in the US
AQ
Hikma continues strong momentum across the Group and upgrades guidance for 2023
AQ
Hikma and CanariaBio sign exclusive licensing agreement to bring Oregovomab to the Middle East and North Africa
AQ
Hikma marks two-year anniversary of KLOXXADO launch by surpassing 375,000 doses donated in the US
AQ
Hikma and SK Biopharmaceuticals enter a strategic partnership for the Middle East and North Africa
AQ
Hikma remains a constituent of the FTSE4Good Index
AQ
Hikma and Rakuten Medical sign exclusive licensing agreement for Alluminox platform cancer treatment for the Middle East and North Africa
AQ
Hikma appoints new President of Injectables business
AQ
Hikma Ventures invests in Octave Bioscience, a precision care platform for Multiple Sclerosis and other neurodegenerative diseases
AQ
Octave Bioscience Closes $30M Extension to Series B Funding
AQ
Hikma Pharmaceuticals PLC - Notice of results
AQ
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action HIK
  4. Actualités Hikma Pharmaceuticals PLC
  5. Communiqués